Michael J. Farrell - Jan 17, 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Executive Officer
Signature
Michael J. Farrell, Chief Executive Officer
Stock symbol
RMD
Transactions as of
Jan 17, 2023
Transactions value $
-$945,481
Form type
4
Date filed
1/18/2023, 03:28 PM
Previous filing
Jan 4, 2023
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $328K +5.68K +1.3% $57.76 443K Jan 17, 2023 Direct F1
transaction RMD ResMed Common Stock Sale -$1.27M -5.68K -1.28% $224.36 437K Jan 17, 2023 Direct F1, F2
holding RMD ResMed Common Stock 4.09K Jan 17, 2023 Lisette and Michael Farrell Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -5.68K -8.61% $0.00 60.2K Jan 17, 2023 ResMed Common Stock 5.68K $57.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 This transaction was executed in multiple trades at prices ranging from $220.59 - $225.635. The price reported above reflects the weighted average sale price.
F3 Represents date options first became exercisable. Options vest 1/3 per year.